Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 3,509 | 3,936 | 2,937 | 2,617 | 3,298 |
| Operating Income | -3,509 | -3,936 | -2,937 | -2,617 | -3,298 |
| Other Income | 18 | 30 | -10 | -1 | 12 |
| Pre-tax Income | -3,491 | -3,906 | -2,947 | -2,618 | -3,286 |
| Net Income Continuous | -3,491 | -3,906 | -2,947 | -2,618 | -3,286 |
| Net Income | $-3,491 | $-3,906 | $-2,947 | $-2,618 | $-3,286 |
| EPS Basic Total Ops | -5.10 | -6.45 | -4.80 | -3.75 | -5.40 |
| EPS Basic Continuous Ops | -5.15 | -6.37 | -4.84 | -3.79 | -5.40 |
| EPS Diluted Total Ops | -5.10 | -6.45 | -4.80 | -3.75 | -5.40 |
| EPS Diluted Continuous Ops | -5.15 | -6.37 | -4.84 | -3.79 | -5.40 |
| EBITDA(a) | $-3,496 | $-3,923 | $-2,925 | $-2,604 | $-3,286 |